The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant chemotherapy for residual disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC).
 
Lauren Christine Harshman
Consulting or Advisory Role - Bristol-Myers Squibb; Dendreon; Medivation/Astellas; NCCN; Pfizer; PlatformQ Health
Research Funding - Bayer; Medivation/Astellas
 
Lillian Werner
No Relationships to Disclose
 
Yu-Ning Wong
Research Funding - Bayer (Inst); Janssen (Inst); Medivation (Inst); Millennium (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - eviti
 
Evan Y. Yu
Honoraria - Amgen; Bayer; Dendreon; Janssen; Medivation; Sanofi
Consulting or Advisory Role - Amgen; Dendreon; Janssen; Medivation; Sanofi
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); GTx (Inst); ImClone Systems (Inst); Janssen (Inst); Oncogenex (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Dendreon; Janssen; Medivation
 
Ajjai Shivaram Alva
Honoraria - Eisai
Consulting or Advisory Role - Eisai
Research Funding - BIND Biosciences; Bristol-Myers Squibb; Genentech; Novartis; Oncogenex
 
Simon J. Crabb
Honoraria - Bayer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer; Sanofi
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Janssen; Novartis; Sanofi
 
Thomas Powles
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; Roche Pharma AG
Research Funding - Astellas Pharma; Exelixis; Genentech/Roche; GlaxoSmithKline
 
Jonathan E. Rosenberg
Stock and Other Ownership Interests - Illumina; Merck
Honoraria - UpToDate
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Johnson & Johnson; Lilly; Merck; Oncogenex; Onyx
Travel, Accommodations, Expenses - Genentech/Roche
 
Jack Baniel
No Relationships to Disclose
 
Ulka N. Vaishampayan
Honoraria - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Research Funding - Astellas Pharma; Exelixis; Novartis
 
Dominik R. Berthold
No Relationships to Disclose
 
Sylvain Ladoire
No Relationships to Disclose
 
Syed A. Hussain
Consulting or Advisory Role - Astellas Pharma; Bayer; Pierre Fabre
Research Funding - Boehringer Ingelheim; Janssen-Cilag; Pierre Fabre
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Boehringer Ingelheim; Janssen-Cilag; MSD Oncology; Pfizer; Pierre Fabre; Roche
 
Matthew I. Milowsky
Research Funding - Astellas Pharma (Inst); BIND Therapeutics (Inst); Dendreon (Inst); Exelixis (Inst); Johnson & Johnson (Inst); Mirati Therapeutics (Inst)
 
Neeraj Agarwal
Research Funding - amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Other Relationship - Exelixis; Medivation; Takeda
 
Andrea Necchi
No Relationships to Disclose
 
Sumanta Kumar Pal
Honoraria - Medivation; Novartis
Consulting or Advisory Role - Aveo; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Federica Recine
No Relationships to Disclose
 
Joaquim Bellmunt
Consulting or Advisory Role - Astellas Pharma; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer
 
Matt D. Galsky
Stock and Other Ownership Interests - Dual Therapeutics
Consulting or Advisory Role - Astellas Pharma; BioMotiv; Dendreon; GlaxoSmithKline; Janssen; Lilly; Merck
Research Funding - Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Oncology (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
Travel, Accommodations, Expenses - Astellas Pharma; BioMotiv; Dendreon; Merck